Variant report
Variant | nsv892806 |
---|---|
Chromosome Location | chr9:24802015-24853876 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:24090178..24090821-chr9:24832388..24833273,3 | MCF-7 | breast: | |
2 | chr9:24844439..24846773-chr9:24846853..24849105,2 | MCF-7 | breast: | |
3 | chr9:24844439..24846773-chr9:24846853..24849105,2 | MCF-7 | breast: | |
4 | chr9:24837279..24839630-chr9:24850767..24853315,2 | MCF-7 | breast: | |
5 | chr9:24837279..24839630-chr9:24850767..24853315,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533216141 | chr9:24803513-24803514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114077441 | chr9:24803521-24803522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143145420 | chr9:24803628-24803629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148316746 | chr9:24803629-24803630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549234227 | chr9:24803647-24803648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192841094 | chr9:24803667-24803668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531457696 | chr9:24803673-24803674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13440224 | chr9:24803746-24803747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545498941 | chr9:24816045-24816046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565416182 | chr9:24816095-24816096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527654140 | chr9:24816113-24816114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547832183 | chr9:24816125-24816126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564719989 | chr9:24816182-24816183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143420600 | chr9:24816199-24816200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1156943 | chr9:24816200-24816201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550087008 | chr9:24816201-24816202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569745737 | chr9:24816209-24816210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528983837 | chr9:24816235-24816236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185064633 | chr9:24816260-24816261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558213991 | chr9:24816276-24816277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs137887610 | chr9:24816289-24816290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568622836 | chr9:24816291-24816292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17699890 | chr9:24816304-24816305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554279520 | chr9:24816390-24816391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574415600 | chr9:24816400-24816401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114946208 | chr9:24816444-24816445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556846319 | chr9:24816517-24816518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538863955 | chr9:24816519-24816520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576698484 | chr9:24816539-24816540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189916174 | chr9:24816542-24816543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565348679 | chr9:24816544-24816545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181193965 | chr9:24816549-24816550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541374207 | chr9:24816556-24816557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561114310 | chr9:24816570-24816571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569267344 | chr9:24816682-24816683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530154714 | chr9:24816739-24816740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549784685 | chr9:24816782-24816783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569967444 | chr9:24816797-24816798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185475422 | chr9:24826803-24826804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142529876 | chr9:24826809-24826810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532225525 | chr9:24826813-24826814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547371356 | chr9:24826824-24826825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9406821 | chr9:24826833-24826834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531739387 | chr9:24826837-24826838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528091190 | chr9:24826838-24826839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548080819 | chr9:24826858-24826859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs77046706 | chr9:24826886-24826887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567961085 | chr9:24826887-24826888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574758717 | chr9:24826888-24826889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs151001716 | chr9:24826914-24826915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Melanoma | 17363583 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Lung cancer | 21569311 | CNVD |
Chordoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:24803400-24803800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:24816000-24816400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr9:24816400-24816800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr9:24826800-24828200 | Enhancers | Fetal Brain Male | brain |
5 | chr9:24834400-24834800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr9:24834400-24835000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr9:24834400-24835000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr9:24834600-24835800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr9:24834800-24835800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr9:24835000-24835800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr9:24835600-24836000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr9:24844600-24844800 | Enhancers | Primary B cells from cord blood | blood |
13 | chr9:24845000-24846000 | Weak transcription | Primary B cells from cord blood | blood |
14 | chr9:24845200-24847400 | Enhancers | Primary B cells from peripheral blood | blood |
15 | chr9:24846000-24847600 | Enhancers | Primary B cells from cord blood | blood |